Valuation: CVRx, Inc.

Market Cap 69M 60.69M 57.39M 52.05M 97.75M 6.62B 98.32M 687M 265M 3.38B 259M 253M 10.86B P/E 2026 *
-1.29x
P/E 2027 * -1.35x
Enterprise Value 79.5M 69.92M 66.12M 59.97M 113M 7.63B 113M 792M 306M 3.89B 298M 292M 12.51B EV / Sales 2026 *
1.35x
EV / Sales 2027 * 1.69x
Free-Float
80.18%
Yield 2026 *
-
Yield 2027 * -
1 day-4.07%
1 week-12.79%
Current month-12.50%
1 month-12.20%
3 months-55.80%
6 months-70.93%
Current year-63.52%
1 week 2.51
Extreme 2.51
2.89
1 month 2.51
Extreme 2.51
3.18
Current year 2.2
Extreme 2.2
9.84
1 year 2.2
Extreme 2.2
11.3
3 years 2.2
Extreme 2.2
33.14
5 years 2.2
Extreme 2.2
33.14
10 years 2.2
Extreme 2.2
33.14
Manager TitleAgeSince
Chief Executive Officer 60 11/02/2024
Director of Finance/CFO 43 30/09/2020
Chief Operating Officer 57 10/08/2025
Director TitleAgeSince
Director/Board Member 61 30/09/2008
Director/Board Member 57 30/06/2020
Director/Board Member 52 30/06/2020
Date Insider Type Main position Quantity % Market Cap. Importance
13/08/26 Buy

Chief Operating Officer

26,223 0.0988%
12/08/26 Sell

Chief Operating Officer

-1,309 0.0049%
01/06/26
Treo Ventures LLC
OtherCompany 0 0% -
Change 5-day change 1-year change 3-year change Capi.($)
-4.07%-12.79%-65.70%-82.94% 69M
+0.09%+0.13%+25.97%+29.33% 12.57B
-0.44%+1.83%+23.46%+29.74% 6.87B
+2.55%-2.98% - - 5.76B
+1.99%-0.24%+41.34%+23.88% 5.5B
+2.47%-0.66%-23.55%+32.84% 5.02B
-0.19%-0.15%-31.20%-23.55% 3.91B
-0.06%-4.23%+22.81%-4.81% 1.84B
+8.75%+13.62%+0.30%+198.19% 1.72B
-2.81%-4.90%+43.70%-16.74% 1.56B
Average +0.83%-1.21%+4.13%+20.66% 4.48B
Weighted average by Cap. +1.02%+0.17%+14.88%+27.61%

Financials

2026 *2027 *
Net sales 58.85M 51.76M 48.95M 44.4M 83.38M 5.65B 83.86M 586M 226M 2.88B 221M 216M 9.26B 66.18M 58.21M 55.04M 49.92M 93.76M 6.35B 94.3M 659M 255M 3.24B 248M 243M 10.42B
Net income -53.45M -47.01M -44.45M -40.32M -75.72M -5.13B -76.16M -532M -206M -2.62B -201M -196M -8.41B -52.14M -45.85M -43.36M -39.33M -73.86M -5B -74.29M -519M -201M -2.55B -196M -191M -8.21B
Net Debt 10.5M 9.24M 8.74M 7.92M 14.88M 1.01B 14.97M 105M 40.39M 514M 39.43M 38.58M 1.65B 42.94M 37.76M 35.71M 32.39M 60.83M 4.12B 61.18M 428M 165M 2.1B 161M 158M 6.76B
Logo CVRx, Inc.
CVRx, Inc. is a commercial-stage medical device company. The Company is focused on developing, manufacturing and commercializing advanced neuromodulation solutions for patients with cardiovascular diseases. The Company's integrated platform technology, Barostim, is designed to leverage the power of the brain and nervous system to address the imbalance of the autonomic nervous system (ANS), which causes heart failure with reduced ejection fraction (HFrEF) and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy (BAT) by sending imperceptible and persistent electrical pulses to baroreceptors located in the wall of the carotid artery to signal the brain to modulate cardiovascular function. Barostim is a minimally invasive neuromodulation device that consists of two implantable components, an implantable pulse generator (IPG) and a stimulation lead, and is programmed by a wireless clinician-controlled programmer that communicates with the IPG.
Employees
223
Date Price Change Volume
28/09/26 US$2.590 -4.07% 381,980
25/09/26 US$2.700 +6.72% 462,364
24/09/26 US$2.530 -6.99% 693,693
23/09/26 US$2.720 -5.88% 482,039
22/09/26 US$2.890 -2.69% 666,182
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
2.590USD
Average target price
4.583USD
Spread / Average Target
+76.96%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CVRX Stock